You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0195 Treatment with anti-tnf biologics in patient with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis does not increase the risk of malignancy

Article metrics

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
FRI0195 Treatment with anti-tnf biologics in patient with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis does not increase the risk of malignancy

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014501
Mar 20141201
Apr 20141301
May 2014801
Jun 2014401
Jul 20141001
Aug 2014100
Sep 2014402
Oct 20141402
Nov 2014501
Dec 2014301
Jan 2015400
Feb 20151502
Mar 2015901
Apr 2015300
May 2015200
Jun 2015100
Jul 2015501
Aug 2015400
Sep 2015700
Nov 2015702
Dec 2015401
Jan 2016601
Feb 2016700
Mar 2016100
Apr 2016502
May 2016400
Jun 2016500
Jul 20161000
Aug 2016500
Sep 2016801
Oct 2016600
Nov 2016900
Dec 2016501
Jan 2017400
Feb 2017400
Mar 2017400
Apr 20171001
May 2017700
Jun 2017301
Aug 20171602
Sep 2017200
Oct 2017200
Nov 2017200
Dec 20171000
Jan 2018400
Feb 2018200
Mar 20181601
Apr 2018800
May 20181401
Jun 2018802
Jul 2018200
Aug 20181600
Sep 2018400
Oct 2018400
Nov 2018800
Dec 2018200
Jan 2019400
Apr 2019200
May 2019600
Jun 2019400
Jul 2019201
Aug 2019200
Oct 2019200
Nov 2019801
Dec 2019500
Mar 2020100
May 2020001
Jul 2020400
Aug 2020100
Sep 2020900
Oct 2020200
Nov 2020400
Dec 2020300
Jan 2021200
Feb 2021100
Mar 2021100
Apr 2021100
May 2021200
Jun 2021100
Jul 2021300
Nov 2021200
Dec 20211400
Jan 2022200
Feb 2022600
Mar 2022200
Apr 2022200
May 2022200
Jul 20221401
Aug 2022600
Sep 2022200
Nov 20221200
Dec 2022400
Jan 2023600
Feb 20232601
Mar 2023600
Apr 2023200
May 2023200
Jun 2023100
Jul 2023200
Sep 2023600
Oct 2023601
Dec 2023400
Mar 2024200
Total564038